Antech Diagnostics

We want to see pets live longer, healthier lives. That’s why we’ve teamed up with VETgirl to offer the Preventive Care for Dogs and Cats Certificate program (43 RACE-approved CE credits) for FREE through December 31, 2024. Ready to prioritize preventive care in your practice? ?? ??Watch this 1-hour webinar in which the 2020 AAHA/AAFP Feline Vaccination Guidelines are reviewed by Task Force member Ellen Carozza! Tune in to learn about: ??What changed in the guidelines. ??The latest recommendations on core/non-core vaccines. ??Lifestyle vaccines based on the patient population. ??Available tools to help practices implement the guidelines. [https://hubs.li/Q02ZfwNL0] ?? And peruse all 48 training modules (including webinars, blogs, and podcasts) here: [https://hubs.li/Q02Zfxyb0]

We want to see pets live longer, healthier lives. That’s why we’ve teamed up with VETgirl to offer the Preventive Care for Dogs and Cats Certificate program (43 RACE-approved CE credits) for FREE through December 31, 2024. Ready to prioritize preventive care in your practice? ?? ????Get the latest scoop on feline vaccines in great (and wildly helpful!) detail from AAFP/AAHA Feline Vaccine Guidelines Task Force Member Ellen Carozza in this VETgirl blog. Plus, she shares how everyone in your practice can support feline vaccination guidelines: [https://hubs.li/Q02ZfzN90] ?? And peruse all 48 training modules (including webinars, blogs, and podcasts) here: [https://hubs.li/Q02ZfB8s0]

Antech’s canine cancer portfolio offers innovative screening and diagnostic solutions delivering rapid results, because the sooner you can get to a diagnosis, the sooner you can provide effective treatments: Nu.Q? on the Element i+ can be used as a part of routine wellness screenings and is indicated for older dogs (≥7 years of age) and younger dogs (≥4 years of age) known to be at a higher risk of developing cancer. CADET BRAF identifies ~85% of TCC/UC cases. CADET BRAF-PLUS provides further evaluation of dogs with clinical signs, but for whom no BRAF mutation is detected, and finds approximately 2/3 of the TCC/UC cases not identified by CADET BRAF. ?? Tap on the link to explore how these tests could transform cancer diagnostics in your practice: https://hubs.li/Q02Zbtc80 *Nu.Q?? is not a confirmatory test for cancer. Nu.Q?? results should act as an impetus to perform additional diagnostics to obtain a diagnosis. Elevated plasma nucleosome concentration does not tell you which cancer is present, and further diagnostics will be needed. Certain inflammatory conditions may increase plasma nucleosome concentration and in these instances Nu.Q? cannot differentiate between cancer and an inflammatory response. Nu.Q? is a registered trademark of VolitionRx Limited and its subsidiaries. The Nu.Q? Canine Cancer Test is supplied to Antech’s Heska affiliate under license by Belgian Volition SRL.

? How concerned do we need to be about Giardia zoonosis? ? Should we be treating pets infected with Giardia but without clinical signs like diarrhea? ? What’s the latest on drug resistance in hookworms? ? Is Echinococcus multilocularis a problem in the U.S. and Canada? Get answers to these One Health questions (and more) in our latest blog featuring Antech’s Global Director of Veterinary Clinical Education, Michelle Evason, BSc, DVM, DACVIM (SAIM), MRCVS. ??Tap the link below to get the rundown on these lowdown parasites. ?? https://hubs.ly/Q02YZRjm0

Your 2025 Antech Directory of Services is going paperless! By going fully digital, you’ll be able to quickly access the up-to-date information you need—anytime, anywhere. The digital 2025 Antech Directory of Services will arrive in your inbox before the end of the year!

The American Veterinary Medical Association estimates that approximately half of dogs aged 10 and older will develop cancer.1 Fast, convenient tools with rapid results are crucial for managing neoplasia, and with Nu.Q? on the Element i+?, you can inform owners of their pet’s risk for certain canine cancers in a matter of minutes during senior patient wellness exams.* Nu.Q? on the Element i+ is the industry's only in-house canine cancer screening blood test to assess the risk for certain diseases, including lymphoma and hemangiosarcoma. Indicated for all dogs aged 7 and older, Nu.Q? on the Element i+ enables you to give pet owners vital information while the patient is still in the exam room. ??Tap the link to discover how Nu.Q? on the Element i+ can help you get (and give) more from senior wellness visits: https://hubs.li/Q02YKV5L0 *Nu.Q?? is not a confirmatory test for cancer. Nu.Q?? results should act as an impetus to perform additional diagnostics to obtain a diagnosis. Elevated plasma nucleosome concentration does not tell you which cancer is present, and further diagnostics will be needed. Certain inflammatory conditions may increase plasma nucleosome concentration and in these instances Nu.Q? cannot differentiate between cancer and an inflammatory response. Nu.Q? is a registered trademark of VolitionRx Limited and its subsidiaries. The Nu.Q? Canine Cancer Test is supplied to Antech’s Heska affiliate under license by Belgian Volition SRL. 1. Cancer in Pets. American Veterinary Medical Association. (2022). Retrieved 9 July 2022, from https://hubs.li/Q02YKRwb0

The speed of Artificial Intelligence. The expertise of leading veterinary radiologists and data scientists. That’s AIS RapidRead??. Click the link below to learn more. https://hubs.li/Q02Y81Vy0

This number becomes even more sobering when you consider how many dogs won’t receive a cancer diagnosis this year –– but should. That’s why Antech offers innovative canine cancer detection and screening options that are both accurate and accessible: ?? Nu.Q? on the Element i+? is the industry's only in-house canine cancer screening blood test to determine the current likelihood of certain diseases, including lymphoma and hemangiosarcoma, helping you refine your differential diagnosis list in minutes.* ?? CADET? BRAF identifies ~85% of transitional cell carcinoma/urothelial carcinoma (TCC/UC) cases by evaluating free-catch urine samples from dogs for the presence of cells harboring the BRAF mutation. ?? CADET? BRAF-PLUS provides further evaluation of dogs with clinical signs, but for whom no BRAF mutation is detected, and finds approximately 2/3 of the TCC/UC cases not identified by CADET BRAF. ??Tap the link to explore these cancer detection tests in more detail: https://hubs.li/Q02X_vYf0 *Nu.Q?? is not a confirmatory test for cancer. Nu.Q?? results should act as an impetus to perform additional diagnostics to obtain a diagnosis. Elevated plasma nucleosome concentration does not tell you which cancer is present, and further diagnostics will be needed. Certain inflammatory conditions may increase plasma nucleosome concentration and in these instances Nu.Q? cannot differentiate between cancer and an inflammatory response. Nu.Q? is a registered trademark of VolitionRx Limited and its subsidiaries. The Nu.Q? Canine Cancer Test is supplied to Antech’s Heska affiliate under license by Belgian Volition SRL. 1. National Cancer Institute: https://hubs.li/Q02X_vM50

Today we honor all those who have served our country in the past and those who continue to serve today.

Practice managers are vital members of the veterinary team whose work often goes unseen, giving us all the more reason to recognize their invaluable contributions! Veterinary practice business health is integral to animal health. Practice managers ensure clinics are equipped to deliver the best care to their patients by overseeing operations, clinic finances, human resources, client communications, and so much more. Thank you for making a better world for pets! ????